51 – 60 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
(
- Contribution to journal › Article
-
Mark
The frequency and outcome of lupus nephritis: results from an international inception cohort study.
(
- Contribution to journal › Article
- 2014
-
Mark
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register
(
- Contribution to journal › Article
-
Mark
25-Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort
(
- Contribution to journal › Article
-
Mark
American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort.
(
- Contribution to journal › Article
- 2013
-
Mark
The Comparison of Trial Data-Based and Registry Data-Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach
(
- Contribution to journal › Article
-
Mark
Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
(
- Contribution to journal › Article
-
Mark
Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial
(
- Contribution to journal › Article
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
(
- Contribution to journal › Article